Clinical and Practical Psychopharmacology
Page 9
Clinical and Practical Psychopharmacology
Metformin for Cardiometabolic Risks in Pediatric Subjects Exposed to Antipsychotics
October 26, 2016
Children and adolescents treated with antipsychotics are at increased risk of weight gain and metabolic dysregulation. In this month’s Clinical and Practical Psychopharmacology column, Chittaranjan Andrade looks at the…
Clinical and Practical Psychopharmacology
Cardiometabolic Risks in Schizophrenia and Directions for Intervention, Part 3
September 28, 2016
Patients with schizophrenia have increased rates of many cardiometabolic risk factors. Chittaranjan Andrade, MD, takes a look at the impact of pharmacological interventions, such as metformin, topiramate, and aripiprazole,…
Clinical and Practical Psychopharmacology
Cardiometabolic Risks in Schizophrenia and Directions for Intervention, Part 2
August 24, 2016
Patients with schizophrenia have increased rates of many cardiometabolic risk factors. In the second in a 2-part series, Chittaranjan Andrade, MD, looks at the impact of nonpharmacological interventions, such…
Clinical and Practical Psychopharmacology
Clinical and Practical Psychopharmacology: Cardiometabolic Risks in Schizophrenia and Directions for Intervention, Part 1
July 27, 2016
It’s well known that patients with schizophrenia have increased cardiometabolic risk factors. In the first of a 2-part series, Chittaranjan Andrade, MD, looks at the magnitude and the moderators…
